First Manhattan’s Cogentix Medical, Inc. CGNT Stock Holding History

First Manhattan’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,770	Closed	-$79K	–	1471
2018 Q1	$79K	Hold	20,770	–	–	﹤0.01%	856
2017 Q4	$65K	Sell	20,770 -600	-3%	-$1.73K	﹤0.01%	945
2017 Q3	$54K	Hold	21,370	–	–	﹤0.01%	938
2017 Q2	$37K	Hold	21,370	–	–	﹤0.01%	991
2017 Q1	$38K	Hold	21,370	–	–	﹤0.01%	995
2016 Q4	$42K	Sell	21,370 -550	-3%	-$1.12K	﹤0.01%	959
2016 Q3	$39K	Hold	21,920	–	–	﹤0.01%	976
2016 Q2	$21K	Hold	21,920	–	–	﹤0.01%	1099
2016 Q1	$24K	Hold	21,920	–	–	﹤0.01%	1037
2015 Q4	$28K	Sell	21,920 -1,150	-5%	-$1.57K	﹤0.01%	1039
2015 Q3	$28K	Hold	23,070	–	–	﹤0.01%	1043
2015 Q2	$37K	Buy	+23,070	New	+$37.8K	﹤0.01%	1025

First Manhattan's CGNT Position: Q2 2018 in Review

First Manhattan sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 20,770 shares — an estimated $79K sold.

First Manhattan first reported a position in CGNT in Q2 2015 and held it in 12 quarters. The position peaked at $79K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

First Manhattan reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
First Manhattan sold 20,770 Cogentix Medical, Inc. shares in Q2 2018, an estimated $79K.
First Manhattan first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 12 quarters.
First Manhattan's Cogentix Medical, Inc. position peaked at $79K in Q1 2018.
0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on First Manhattan's 13F filing for Q2 2018, filed 1 Aug 2018.